1.Knock-down of long intergenic noncoding RNA cyclooxygenase 2 (lincRNA-COX2) inhibits apoptosis and polarization into M1 in Listeria monocytogenes-infected macrophages.
Yurong ZHU ; Shuang HUANG ; Lin LIN ; Fengyuan ZHANG ; Xugan JIANG ; Shengxia CHEN
Chinese Journal of Cellular and Molecular Immunology 2023;39(4):289-294
Objective To investigate the effect of long intergenic non-coding RNA COX2 (lincRNA-COX2) on apoptosis and polarization of Listeria monocytogenes (Lm)-infected RAW264.7 cells. Methods RAW264.7 cells were cultured and divided into control group (uninfected cells), Lm infection group, negative control of small interfering RNA (si-NC) group, si-NC and Lm infection group, small interfering RNA of lincRNA-COX2 (si-lincRNA-COX2) group, si-lincRNA-COX2 and Lm infection group. RAW264.7 cells were infected with MOI=10 Lm for 6 hours, and then the inhibition efficiency of siRNA transfection was detected by fluorescence microscope and quantitative real-time PCR (qRT-PCR). The expression levels of cleaved-caspase-3(c-caspase-3), caspase-3, B-cell lymphoma-2 (Bcl2), Bcl2 associated X protein (BAX), arginase 1 (Arg1), inducible nitric oxide synthase (iNOS) were detected by Western blot analysis. Results c-caspase-3/caspase-3, BAX/Bcl2 and iNOS were significantly up-regulated, while the level of Arg1 was down-regulated in Lm-infected RAW264.7 cells compared with control group. LincRNA-COX2 knockdown inhibited the increase of protein levels for BAX/Bcl2, c-caspase-3/caspase-3 and iNOS in Lm-infected RAW264.7 cells, while the level of Arg1 in Lm-infected RAW264.7 cells was up-regulated. Conclusion Knockdown of lincRNA-COX2 can inhibit cell apoptosis and suppress the macrophage polarization into M1 type in Lm-infected RAW264.7 cells.
Apoptosis/genetics*
;
bcl-2-Associated X Protein/metabolism*
;
Caspase 3/metabolism*
;
Cyclooxygenase 2/metabolism*
;
Listeria monocytogenes/pathogenicity*
;
Macrophages/microbiology*
;
RNA, Long Noncoding/metabolism*
;
RNA, Small Interfering/genetics*
;
Animals
;
Mice
2.Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway.
Shuang LEI ; Jian LI ; Jingjun YU ; Fulong LI ; Yaping PAN ; Xu CHEN ; Chunliang MA ; Weidong ZHAO ; Xiaolin TANG
International Journal of Oral Science 2023;15(1):3-3
Bacteremia induced by periodontal infection is an important factor for periodontitis to threaten general health. P. gingivalis DNA/virulence factors have been found in the brain tissues from patients with Alzheimer's disease (AD). The blood-brain barrier (BBB) is essential for keeping toxic substances from entering brain tissues. However, the effect of P. gingivalis bacteremia on BBB permeability and its underlying mechanism remains unclear. In the present study, rats were injected by tail vein with P. gingivalis three times a week for eight weeks to induce bacteremia. An in vitro BBB model infected with P. gingivalis was also established. We found that the infiltration of Evans blue dye and Albumin protein deposition in the rat brain tissues were increased in the rat brain tissues with P. gingivalis bacteremia and P. gingivalis could pass through the in vitro BBB model. Caveolae were detected after P. gingivalis infection in BMECs both in vivo and in vitro. Caveolin-1 (Cav-1) expression was enhanced after P. gingivalis infection. Downregulation of Cav-1 rescued P. gingivalis-enhanced BMECs permeability. We further found P. gingivalis-gingipain could be colocalized with Cav-1 and the strong hydrogen bonding between Cav-1 and arg-specific-gingipain (RgpA) were detected. Moreover, P. gingivalis significantly inhibited the major facilitator superfamily domain containing 2a (Mfsd2a) expression. Mfsd2a overexpression reversed P. gingivalis-increased BMECs permeability and Cav-1 expression. These results revealed that Mfsd2a/Cav-1 mediated transcytosis is a key pathway governing BBB BMECs permeability induced by P. gingivalis, which may contribute to P. gingivalis/virulence factors entrance and the subsequent neurological impairments.
Animals
;
Rats
;
Bacteremia/metabolism*
;
Blood-Brain Barrier/microbiology*
;
Caveolin 1/metabolism*
;
Gingipain Cysteine Endopeptidases/metabolism*
;
Permeability
;
Porphyromonas gingivalis/pathogenicity*
;
Transcytosis
;
Virulence Factors/metabolism*
3.Phylogenetic and pathogenicity analysis of influenza B virus strain B/Guangxi-Jiangzhou/1352/2018.
Qingxin MENG ; Pengtao JIAO ; Lei SUN ; Dayan WANG ; Tingrong LUO ; Wenhui FAN ; Wenjun LIU
Chinese Journal of Biotechnology 2022;38(9):3390-3405
Influenza B virus (IBV) is more likely to cause complications than influenza A virus (IAV) and even causes higher disease burden than IAV in a certain season, but IBV has received less attention. In order to analyze the genetic evolution characteristics of the clinical strain IBV (B/Guangxi-Jiangzhou/1352/2018), we constructed genetic evolution trees and analyzed the homology and different amino acids of hemagglutinin and neuraminidase referring to the vaccine strains recommended by World Health Organization (WHO). We found that strain B/Guangxi-Jiangzhou/1352/2018 was free of interlineage reassortment and poorly matched with the vaccine strain B/Colorado/06/2017 of the same year. We also determined the median lethal dose (LD50) and the pathogenicity of strain B/Guangxi-Jiangzhou/1352/2018 in mice. The results showed that the LD50 was 105.9 TCID50 (median tissue culture infective dose), the IBV titer in the lungs reached peak 1 d post infection and the mRNA level of the most of inflammatory cytokines in the lungs reached peak 12 h post infection. The alveoli in the lungs were severely damaged and a large number of inflammatory cells were infiltrated post infection. The study demonstrated that the clinical strain IBV (B/Guangxi-Jiangzhou/1352/2018) could infect mice and induce typical lung inflammation. This will facilitate the research on the pathogenesis and transmission mechanism of IBV, and provide an ideal animal model for evaluation of new vaccines, antiviral and anti-inflammatory drug.
Amino Acids/genetics*
;
Animals
;
Antiviral Agents/pharmacology*
;
China
;
Cytokines/metabolism*
;
Hemagglutinins/metabolism*
;
Humans
;
Influenza B virus/pathogenicity*
;
Influenza, Human/virology*
;
Mice
;
Neuraminidase/genetics*
;
Orthomyxoviridae Infections/virology*
;
Phylogeny
;
RNA, Messenger/metabolism*
;
Virulence/genetics*
4.Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19.
Lunzhi YUAN ; Huachen ZHU ; Ming ZHOU ; Jian MA ; Rirong CHEN ; Liuqin YU ; Wenjia CHEN ; Wenshan HONG ; Jia WANG ; Yao CHEN ; Kun WU ; Wangheng HOU ; Yali ZHANG ; Shengxiang GE ; Yixin CHEN ; Quan YUAN ; Qiyi TANG ; Tong CHENG ; Yi GUAN ; Ningshao XIA
Protein & Cell 2022;13(1):72-77
Animals
;
Antibodies, Neutralizing/biosynthesis*
;
Antibodies, Viral/biosynthesis*
;
Body Weight/immunology*
;
COVID-19/virology*
;
Disease Models, Animal
;
Disease Progression
;
Humans
;
Immunohistochemistry
;
Lung/virology*
;
Male
;
Mesocricetus
;
Nasal Cavity/virology*
;
RNA, Viral/immunology*
;
SARS-CoV-2/pathogenicity*
;
Severity of Illness Index
;
Viral Load
5.Isolation and Characterization of
Tian QIN ; Lu Xi JIANG ; Hong Yu REN ; Xue Yang JIA ; Xu Dong NIE ; Yi Nan LI
Biomedical and Environmental Sciences 2021;34(10):834-837
6.ADP-ribosylhydrolases: from DNA damage repair to COVID-19.
Lily YU ; Xiuhua LIU ; Xiaochun YU
Journal of Zhejiang University. Science. B 2021;22(1):21-30
Adenosine diphosphate (ADP)-ribosylation is a unique post-translational modification that regulates many biological processes, such as DNA damage repair. During DNA repair, ADP-ribosylation needs to be reversed by ADP-ribosylhydrolases. A group of ADP-ribosylhydrolases have a catalytic domain, namely the macrodomain, which is conserved in evolution from prokaryotes to humans. Not all macrodomains remove ADP-ribosylation. One set of macrodomains loses enzymatic activity and only binds to ADP-ribose (ADPR). Here, we summarize the biological functions of these macrodomains in DNA damage repair and compare the structure of enzymatically active and inactive macrodomains. Moreover, small molecular inhibitors have been developed that target macrodomains to suppress DNA damage repair and tumor growth. Macrodomain proteins are also expressed in pathogens, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, these domains may not be directly involved in DNA damage repair in the hosts or pathogens. Instead, they play key roles in pathogen replication. Thus, by targeting macrodomains it may be possible to treat pathogen-induced diseases, such as coronavirus disease 2019 (COVID-19).
ADP-Ribosylation
;
COVID-19/metabolism*
;
DNA Repair/physiology*
;
Evolution, Molecular
;
Humans
;
Models, Biological
;
Models, Molecular
;
N-Glycosyl Hydrolases/metabolism*
;
Poly(ADP-ribose) Polymerases/metabolism*
;
Protein Domains
;
SARS-CoV-2/pathogenicity*
7.In Vitro Antimicrobial Activity and Aggregation Abilities of Probiotic Lactobacillus casei and Lactobacillus salivarius Against Oral Pathogens
Darshyna Theena Thayalan ; Rosmaliza Abdullah ; Siti Suraiya Md Noor ; Suharni Mohamad
Archives of Orofacial Sciences 2021;16(2):153-163
ABSTRACT
The antagonistic effect of probiotics against oral pathogens merits exploration because these bacteria are
beneficial to the host’s health. The antimicrobial activity of two probiotic strains, Lactobacillus casei and
Lactobacillus salivarius, as well as L. casei and L. salivarius combination (1:1), was investigated against
Streptococcus mutans, Streptococcus sobrinus, Candida albicans, Candida glabrata and Candida tropicalis
using agar-well diffusion, auto-aggregation and coaggregation assays. L. salivarius cell-free supernatant
(CFS) alone exhibited greater inhibitory effect against Streptococci spp. compared to L. casei CFS alone
and the combination. However, no inhibition was observed for Candida spp. L. salivarius alone exhibited
significantly stronger auto-aggregation than L. casei alone (p ≤ 0.05) and L. casei and L. salivarius
combination. L. salivarius exhibited strong coaggregation ability with Candida spp., followed by
Streptococci spp. while L. casei exhibited coaggregation only with Streptococci spp. However, L. casei and
L. salivarius combination did not display any coaggregation with all strains. L. salivarius alone exhibited
a stronger antagonistic effect on the tested organisms than L. casei alone or in combination. Based on the
results, both probiotic strains showed good antimicrobial activities against oral pathogens and should be
further studied for their human health benefits.
Lacticaseibacillus casei--pathogenicity
;
Ligilactobacillus salivarius--pathogenicity
8.Comparative Study of the Genetic Diversity, Antimicrobial Resistance, and Pathogenicity of
Shuang MENG ; Xiao Li DU ; Yong Lu WANG ; Feng Tian QU ; Gui Lin XIE ; Hai Jian ZHOU ; Jin Rui HU ; Zheng QIN ; Yue WANG ; Biao KAN ; Zhi Gang CUI
Biomedical and Environmental Sciences 2021;34(6):454-464
Objective:
This study was performed to compare the genetic diversity, virulence, and antimicrobial resistance of
Methods:
A total of 38 clinical strains and 19 strains from healthy individuals were isolated from the samples collected in Ma'anshan City, Anhui Province. Their taxonomy was investigated using concatenated
Results:
The 57
Conclusions
The taxonomy, virulence properties, and antibiotic resistance of
Aeromonas/pathogenicity*
;
Case-Control Studies
;
Drug Resistance, Bacterial/genetics*
;
Genetic Variation
;
Humans
;
Virulence Factors/genetics*
9.Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection.
Wanyin TAO ; Xiaofang WANG ; Guorong ZHANG ; Meng GUO ; Huan MA ; Dan ZHAO ; Yong SUN ; Jun HE ; Lianxin LIU ; Kaiguang ZHANG ; Yucai WANG ; Jianping WENG ; Xiaoling MA ; Tengchuan JIN ; Shu ZHU
Protein & Cell 2021;12(3):230-235


Result Analysis
Print
Save
E-mail